NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,602 | -5.9% | 55 | -6.8% | 0.01% | +25.0% |
| Q2 2023 | $5,954 | +9.7% | 59 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,428 | -15.7% | 59 | -16.9% | 0.00% | -20.0% |
| Q4 2022 | $6,441 | +28.8% | 71 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $5,000 | -16.7% | 71 | -5.3% | 0.00% | -20.0% |
| Q2 2022 | $6,000 | -14.3% | 75 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $7,000 | +40.0% | 75 | +25.0% | 0.01% | +66.7% |
| Q4 2021 | $5,000 | +25.0% | 60 | +27.7% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -20.0% | 47 | -13.0% | 0.00% | -25.0% |
| Q4 2020 | $5,000 | -61.5% | 54 | -63.0% | 0.00% | -66.7% |
| Q3 2020 | $13,000 | 0.0% | 146 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $13,000 | +225.0% | 146 | +147.5% | 0.01% | +180.0% |
| Q1 2020 | $4,000 | -20.0% | 59 | -1.7% | 0.01% | 0.0% |
| Q4 2019 | $5,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |